Concepedia

Michael Robbins

MR

45

Publications

4K

Citations

30

H-Index

1969

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pfizer (United States)

University of Michigan

Harvard University

Dana-Farber Cancer Institute

Michael Robbins is an author at Bristol-Myers Squibb (United States) specializing in medicine, social sciences, and psychology.

ORCID

Top concepts

Publications per year

1969–2021

45

Publications

45

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Meletios Α. Dimopoulos, Dominik Dytfeld, Sebastian Grosicki et al. · New England Journal of Medicine · 2018 · 526 citations · Full text

Clinical Genetic Testing for Patients With Autism Spectrum Disorders

Yiping Shen, Kira A. Dies, Ingrid A. Holm et al. · PEDIATRICS · 2010 · 392 citations · Full text

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A

Ellen Chuang, Timothy S. Fisher, Rodney Morgan et al. · Immunity · 2000 · 292 citations · Full text

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

Andrzej Jakubowiak, Massimo Offidani, Brigitte Pegourié et al. · Blood · 2016 · 231 citations · Full text

Copy number variation plays an important role in clinical epilepsy

Heather E. Olson, Yiping Shen, Jennifer Avallone et al. · Annals of Neurology · 2014 · 171 citations

Rows per page

1–5 of 45